Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented final first-in-human data for ...
A two-part adaptation of Stephen King's iconic novel of the same name. Seven children in Derry, Maine are terrorized by an eponymous being, only to face their own personal demons in the process. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results